Mutation of TP53, as occurs in LFS, not only neutralizes the P53 protein’s normal tumor suppressive function, but may also disrupt cellular regulatory networks, thus enabling tumor cells to avoid genotoxic signals such as from gamma radiation, circumventing senescence and programmed cell death [21,24,25,26]. The gene discussed is TP53; the disease is neoplasm.